Dr. Abazeed's lab focuses on understanding the complexities of small cell lung carcinoma (SCLC), a challenging type of cancer that is often resistant to treatment. The lab explores how cancer cells can change their behavior and characteristics in response to therapies, which helps uncover new strategies for overcoming these resistances. By studying the different states of SCLC cells, the team aims to develop innovative therapeutic approaches that can improve treatment outcomes for patients.

Dr. Daniel Abebayehu's lab at the University of Virginia focuses on understanding how inflammatory fibroblasts influence the wound healing process. By investigating the interactions between immune and stromal cells, the lab aims to pinpoint why some wounds heal properly while others lead to fibrosis, a condition that contributes to a significant number of deaths in the developed world. Through advanced techniques and models, the lab seeks to uncover new therapeutic targets to improve wound healing outcomes and address fibrotic disorders.

Dr. Samuel Achilefu's lab focuses on creating advanced nanomedicine techniques to help treat cancer and bone diseases. By developing tiny particles that can deliver therapy precisely to tumors without needing oxygen or light penetration, the team aims to improve patient outcomes significantly. Their innovative approach utilizes unique properties of inorganic nanoparticles to enhance therapeutic results, especially in difficult-to-treat conditions.

Dr. Ranjit Bindra's lab at Yale University focuses on understanding and treating acute myeloid leukemia (AML), particularly in patients with mutations in genes called IDH1 and IDH2. These mutations disrupt important DNA repair processes, making cancer cells vulnerable to specific therapies. The lab is investigating new ways to combine existing drugs to enhance treatment effectiveness, especially for patients who have not responded well to current therapies.

Dr. Steve Bin Jiang's lab focuses on improving cancer treatment through advanced technologies in radiotherapy. They are developing an Artificial Intelligence-based system to enhance quality assurance for a new type of radiotherapy known as MR-LINAC, which combines radiation treatment with MRI imaging. This innovative approach aims to ensure that cancer treatments are safer and more personalized by accurately adapting to changes in a patient's anatomy over time.

Dr. Rajesh Narendran's lab at the University of Pittsburgh focuses on understanding the interactions between stress, neuropeptides, and addiction. The research aims to uncover how certain brain systems, like the nociceptin opioid peptide receptor system, influence relapse in alcohol and cocaine use disorders. By using advanced imaging techniques, the lab investigates how these systems respond to stress and how they can potentially be targeted for therapeutic interventions in addiction.

Dr. Sadek Nehmeh's lab focuses on advancing brain imaging technology to enhance the diagnosis and monitoring of neurological disorders and brain tumors. His team is developing a new ultra-high performance PET scanner that promises superior imaging capabilities compared to existing technologies, enabling early diagnosis and treatment of brain diseases. With a collaborative approach, the lab combines expertise in engineering, imaging, and clinical applications to create a cutting-edge tool for neurology and neuro-oncology.

Dr. Sunil J Advani's lab focuses on improving treatments for locally advanced cancers through innovative therapies that combine radiotherapy with targeted drug delivery. The lab utilizes antibody drug conjugates (ADCs) to specifically deliver radiosensitizers to cancer cells, enhancing tumor control while minimizing damage to normal tissues. Through examining the immune response in the tumor microenvironment, the lab aims to develop molecularly guided precision therapies that are more effective and less toxic than conventional treatments.

Dr. Zhongping Chen's lab focuses on creating advanced imaging technologies for better understanding and detecting coronary artery disease (CAD). The research aims to develop a sophisticated imaging system that combines different modalities to assess the vulnerability of atherosclerotic plaques. By using this technology, the lab hopes to enhance clinical management and treatment customization for patients with heart disease.

Dr. Randy Carney's lab at UC Davis focuses on creating advanced drug delivery systems using engineered extracellular vesicles (EVs) and studying the environmental and health impacts of nanoplastics. His team aims to improve how drugs can effectively reach the brain while reducing side effects and investigating how polluted nanoplastics can harm health by entering the brain after inhalation. This research combines engineering with biology to find solutions to significant health and environmental challenges.

Dr. Eugene Thomas Pashuck's lab at Lehigh University focuses on creating advanced hydrogels that mimic the natural environments of different cell types. By utilizing protease-responsive materials, the lab aims to develop specialized niches within these hydrogels, which can support various physiological functions like blood vessel formation and bone development. Their work is crucial for improving tissue engineering and regenerative medicine applications.

Dr. Joseph Y Lo's research lab at Duke University focuses on improving how radiologists analyze complex body CT scans using advanced artificial intelligence (AI) tools. The lab is working on creating a computer-aided diagnosis triage tool that helps radiologists prioritize scans with actionable diseases. By leveraging large datasets and innovative deep learning techniques, the lab aims to enhance diagnostic performance and streamline workflow in medical imaging, ultimately benefiting patient care.

Cristina L. Zavaleta's lab at the University of Southern California focuses on developing advanced imaging technologies to better understand patient tissues, particularly in cancer research. Her team's innovative approach uses special nanoparticles to provide detailed molecular profiles in a single image, enhancing the way physicians can analyze tissue samples. This work aims to improve personalized treatment by effectively profiling the immune response within tumors and other diseases.

Dr. Vijay Sharma's lab focuses on developing advanced PET imaging techniques to investigate the role of oxidative stress and inflammation in various diseases, particularly neurodegenerative disorders like Alzheimer's and chemotherapy-induced cardiotoxicity. The research aims to create novel imaging agents that can help visualize cellular processes related to mitochondrial function and response to treatments. By utilizing these new imaging tools, the lab hopes to enhance early diagnosis and improve the management of chronic diseases.

Dr. Yuan-Chuan Tai's lab focuses on developing advanced imaging technologies to enhance targeted radiopharmaceutical therapies for cancer treatment. Their innovative projects aim to create systems that allow for improved visualization and quantification of therapeutic agents within the body, thereby optimizing personalized medicine approaches. This research can lead to significant advancements in how therapies are administered and monitored, ultimately improving patient outcomes.

Dr. Jiang Du's research lab focuses on advanced MRI techniques to improve the diagnosis and understanding of Alzheimer's disease and knee osteoarthritis. They are developing novel imaging biomarker technologies that can detect early pathological changes in myelin for Alzheimer's and measure joint tissue changes associated with osteoarthritis. The lab aims to enhance both diagnostic capabilities and treatment monitoring through innovative imaging methodologies.

Dr. Lin Z. Li's research lab focuses on developing advanced imaging techniques to enhance the prognosis of early-stage triple negative breast cancer. By using a method called Optical Redox Imaging, the lab aims to identify metabolic variations within tumors that could inform treatment strategies and improve patient outcomes. Their work is essential for creating better diagnostic tools that predict disease progression, leading to more personalized treatment approaches for cancer patients.

Dr. Song Hu's lab at Washington University focuses on developing advanced imaging techniques to study diseases like myofascial pain, Alzheimer's disease, and stroke. The lab creates innovative tools for tracking brain and muscle function over time, helping to identify the mechanisms behind these conditions, and developing new therapies. Ultimately, their research aims to improve diagnosis and treatment options for neurological and pain disorders.

Dr. Katherine Ferrara's lab focuses on developing advanced imaging technologies to enhance medical procedures, particularly in the fields of interventional radiology and oncology. The lab is working on innovative ultrasound imaging techniques that can provide high-resolution images without radiation exposure, making it safer for patients undergoing procedures like biopsies and treatments for liver and breast cancer. They are also developing specialized imaging systems for children and investigating targeted therapies for pancreatic cancer.

Dr. David Cormode's lab at the University of Pennsylvania focuses on enhancing breast cancer screening techniques using advanced materials. They are developing silver telluride nanoparticles as contrast agents for dual-energy mammography, aimed at improving tumor detection, especially in women with dense breast tissue. This research combines innovative nanoparticle technology with clinical applications to aim for better outcomes in breast cancer detection and treatment.